基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 一抗 其他一抗 ACTN1 antibody ACTN1抗体
  • ACTN1抗体
  • ACTN1抗体
  • ACTN1抗体

1/3

ACTN1抗体

Rabbit Polyclonal ACTN1 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-13

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
ACTN1抗体
英文名称:
Rabbit Polyclonal ACTN1 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 3779 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
ACTN1

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/15-1/50 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/5000 Human,Mouse,Rat
   

产品详情

AliasesBDPLT15
WB Predicted band size103/106 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human ACTN1
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 6%SDS-PAGE, Lysate: 40 μg, Lane 1-4: 231, A549 and Hela cell, Human fetal muscle tissue lysates, Primary antibody: P07829(ACTN1 Antibody) at dilution 1/500, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 20 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P07829(ACTN1 Antibody) at dilution 1/10. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human colon cancer tissue using P07829(ACTN1 Antibody) at dilution 1/10. (Original magnification: ×200)    


           

参考文献

以下是关于ACTN1抗体的3篇示例参考文献及其摘要概括:

1. **《ACTN1 mutations cause congenital macrothrombocytopenia》**

*Kunishima S, et al.*

摘要:研究揭示ACTN1基因突变通过破坏α-actinin-1蛋白的细胞骨架功能,导致先天性巨血小板减少症。研究利用ACTN1抗体进行免疫印迹和免疫荧光,证实突变体蛋白表达异常及血小板形态缺陷。

2. **《Alpha-actinin-1 regulates cell adhesion and metastasis in colorectal cancer》**

*Honda K, et al.*

摘要:探讨α-actinin-1在结直肠癌细胞迁移和转移中的作用,通过ACTN1抗体敲低实验表明其调控黏着斑动力学,抑制ACTN1可减少癌细胞侵袭能力。

3. **《Structural basis of α-actinin-1 interaction with platelet integrins》**

*Sjöblom B, et al.*

摘要:结合X射线晶体学和ACTN1抗体的共沉淀实验,解析α-actinin-1与血小板整合素β3的互作机制,揭示其在血栓形成中的关键结构域。

4. **《ACTN1 deficiency impairs megakaryocyte maturation and platelet release》**

*Berrou E, et al.*

摘要:通过小鼠模型和ACTN1抗体标记,证明α-actinin-1缺失导致巨核细胞成熟障碍及血小板生成减少,提示其在造血系统中的必要功能。

(注:以上文献为示例,实际引用时请核实具体来源及细节。)

       

背景信息

ACTN1 (alpha-actinin-1) is a cytoskeletal protein belonging to the α-actinin family, which plays a critical role in crosslinking actin filaments and anchoring them to cellular structures. Expressed in non-muscle cells, ACTN1 is involved in maintaining cell shape, adhesion, migration, and signaling by linking the actin cytoskeleton to membrane-associated protein complexes, such as integrins at focal adhesions. ACTN1 antibodies are essential tools for studying its expression, localization, and function in cellular processes. These antibodies are widely used in techniques like Western blotting, immunofluorescence, and immunohistochemistry to investigate ACTN1's role in diseases, including cancer, cardiovascular disorders, and immune dysfunction. For instance, altered ACTN1 expression has been linked to tumor metastasis and platelet abnormalities. Structurally, ACTN1 contains an N-terminal actin-binding domain, central spectrin repeats, and a C-terminal calmodulin-like domain, with specific antibodies often targeting these regions to explore functional domains or post-translational modifications. Due to its involvement in cytoskeletal dynamics, ACTN1 is also studied in contexts like wound healing and immune cell activation. Commercially available ACTN1 antibodies vary in host species, clonality, and applications, requiring validation for specificity across experimental models. Research continues to clarify its regulatory mechanisms and therapeutic potential in cytoskeleton-related pathologies.
       
ACTN1抗体;ACTN1;ACTN1 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

ACTN1抗体相关厂家报价

内容声明
拨打电话 立即询价